Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Qinetiq Share Price
  4. Qinetiq Share Regulatory News
  5. Director Declaration

Pin to quick picksQinetiq Regulatory News (QQ.)

Qinetiq Information

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Director Declaration

14 Apr 2026 13:38

RNS Number : 4447A
QinetiQ Group plc
14 April 2026
 

QinetiQ Group plc

 

Non-Executive Director Declaration

 

14 April 2026 -QinetiQ Group plc ('QinetiQ') has been notified that Steve Mogford, Senior Independent Non-Executive Director, will succeed Andy Martin as Chairman of the Board of Intertek Group plc, a Company Listed on the London Stock Exchange following their Annual General Meeting on 20 May 2026.

 

 

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,000 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Andrew Carter, Group Director Investor Relations:

+44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFZGMDZDVGVZM
91011121314151617
Date   Source Headline
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
91011121314151617

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SST
Scottish Oriental Smaller Companies Trust
LSE
-0.74%
WPP
WPP
LSE
-3.17%
CRS
Crystal Amber
LSE
0.00%
EXR
Engage Xr
LSE
0.00%
SAIN
Scot.amer.inv.
LSE
-0.36%
Trending
AVCT
Avacta Group
LSE
2.14%
ALRT
Defence Holdings
LSE
19.05%
ITM
Itm Power
LSE
-10.85%
NANO
Nanoco
LSE
-10.69%
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%